Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

M-55529: A novel, selective factor Xa inhibitor from Mochida

May 5, 2004

PAI-1 inhibitors designed and synthesized at Wyeth

April 22, 2004

rhThrombin enters phase II

April 21, 2004

Eisai describes novel, potent orally active small molecule thrombin receptor antagonists

April 19, 2004

GlaxoSmithKline to acquire Fraxiparine and Arixtra

April 19, 2004

Merck KGaA team presents novel inhibitors of factor Xa and other coagulation factors

April 13, 2004

Novel orally effective PAI-1 inhibitor for fibrinolytic dysfunction

March 30, 2004

PARP inhibitor HO-3089 demonstrates both cardioprotective and antithrombotic potential

March 25, 2004

Transgenomic to manufacture components of regulatable anticoagulant therapy

March 24, 2004

Novel GP IIb/IIIa antagonists from Millennium

March 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...